FindTrial
Sign In

A double blind parallel group randomised placebo controlled trial of Propranolol and Pizotifen in preventing migraine in children.

A double blind parallel group randomised placebo controlled trial of Propranolol and Pizotifen in preventing migraine in children.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
EU CTR
Registry ID
EUCTR2006-005107-34-GB
Enrollment
Unknown
Registered
2009-04-16
Start date
2009-05-28
Completion date
Unknown
Last updated
2012-03-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Children and young people aged 5 years-16 years with Migraine with Out aura (MO), Migraine with Aura (MA), or Probable Migraine (PM) as defined by the International Headache Society (IHS) with 2 to 6 migraine or probable migraine attacks per 4 week period by history during the previous 3 months and treating paediatrician and parent / guardian and child or young person believe the attacks are currently frequent and severe enough to merit a twice daily preventative medication. MedDRA version: 8.1

Interventions

Trade Name: Syprol Oral Solution Product Name: Propranolol Pharmaceutical Form: Oral liquid Pharmaceutical form of the placebo: Oral liquid Route of administration of the placebo: Oral use Trade Nam

Sponsors

University of Nottingham
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Are the trial subjects under 18? yes Number of subjects for this age range: F.1.2 Adults (18-64 years) no F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) no F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Main Objective: ;Secondary Objective: ;Primary end point(s):—

Countries

United Kingdom

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026